Key result
Mutational analysis identified IDH1/2 mutations in 16 of 17 successfully tested sporadic spindle cell hemangiomas, demonstrating high specificity for this lesion.
Why the study?
Does smMIP-based NGS improve the detection of IDH1/2 mutations in sporadic spindle cell hemangiomas compared to conventional methods?
Observational (n=19)
Does smMIP-based NGS improve the detection of IDH1/2 mutations in sporadic spindle cell hemangiomas compared to conventional methods?
IDH1/2 mutations are highly specific for spindle cell hemangiomas and can be effectively detected using smMIP-based NGS, overcoming challenges related to mosaicism.
Answers are grounded in this paper and cite their sources.
smMIP-NGS detects IDH1/2 mutations in most sporadic SCH; leaves open routine diagnostic adoption pending validation.
Spindle cell hemangioma (SCH) is a distinct vascular soft-tissue lesion characterized by cavernous blood vessels and a spindle cell component mainly occurring in the distal extremities of young adults. The majority of cases harbor heterozygous mutations in IDH1/2 sporadically or rarely in association with Maffucci syndrome. However, based on mosaicism and accordingly a low percentage of lesional cells harboring a mutant allele, detection can be challenging. We tested 19 sporadic SCHs by Sanger sequencing, multiplex ligation-dependent probe amplification (MLPA), conventional next generation sequencing (NGS), and NGS using a single molecule molecular inversion probes (smMIP)-based library preparation to compare their diagnostic value. Out of 10 cases tested by Sanger sequencing and 2 analyzed using MLPA, 4 and 1, respectively, revealed a mutation in IDH1 (p.R132C). The 7 remaining negative cases and additional 6 cases were investigated using smMIP/NGS, showing hot spot mutations in IDH1 (p.R132C) (8 cases) and IDH2 (3 cases; twice p.R172S and once p.R172G, respectively). One case was negative. Owing to insufficient DNA quality and insufficient coverage, 2 cases were excluded. In total, in 16 out of 17 cases successfully tested, an IDH1/2 mutation was found. Given that IDH1/2 mutations were absent in 161 other vascular lesions tested by smMIP/NGS, the mutation can be considered as highly specific for SCH.
No takes yet. Share an insight, caveat, or question.
Broek et al. (2017) conducted an observational in sporadic spindle cell hemangiomas (n=19). smMIP-based next generation sequencing vs. Sanger sequencing and MLPA was evaluated on Detection of IDH1/2 mutations. Mutational analysis identified IDH1/2 mutations in 16 of 17 successfully tested sporadic spindle cell hemangiomas, demonstrating high specificity for this lesion.
Synapse has enriched 10 related papers. Consider them for comparative context: